Evommune, Inc. (EVMN) — Defensive Interval Ratio

Latest as of December 2025: 2143 days

Evommune, Inc. (EVMN) has a Defensive Interval Ratio of 2143 days as of December 2025. Defensive assets of $105.14 Million (cash $-, short-term investments $105.14 Million, receivables $-) cover 2143 days of daily cash needs of $49.07K/day. See EVMN net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

2143 days
Days of operational coverage

Defensive Assets

$105.14 Million
Cash + ST Investments + Receivables

Daily Cash Need

$49.07K
Current Liabilities ÷ 365

Current Liabilities

$17.91 Million
USD

Evommune, Inc. Defensive Interval Ratio (2023–2025)

This chart shows how Evommune, Inc.'s Defensive Interval Ratio has evolved across 3 annual periods from 2023 to 2025. As of December 2025, the ratio stands at 2143 days, meaning defensive assets of $105.14 Million can fund 2143 days of operations without new revenue. See how leveraged is Evommune, Inc.'s balance sheet to measure how much of total assets are equity-financed.

Annual Defensive Interval Ratio for Evommune, Inc. (2023–2025)

The table below presents the year-by-year Defensive Interval Ratio for Evommune, Inc. from 2023 to 2025, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see how much is Evommune, Inc. worth.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2025 2143 days $105.14 Million $49.07K/day $- $105.14 Million ▲ +1415 days
2024 728 days $55.78 Million $76.66K/day $- $55.78 Million ▼ -1937 days
2023 2665 days $50.06 Million $18.79K/day $- $50.06 Million
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)